Less Than Half of NSCLC Patients Received Comprehensive Biomarker Testing in a Real-World Study – Cancer Therapy Advisor
Real-World research study reveals less than half of NSCLC patients receive comprehensive biomarker testing prior to receiving 1st line therapy. CONTEXT: A retrospective chart review of metastatic NSCLC patients presented Continue Reading